Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-09-000121
Filing Date
2009-03-13
Accepted
2009-03-13 17:06:27
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a51298e10vk.htm 10-K 2102269
2 EX-10.34 a51298exv10w34.htm EX-10.34 9542
3 EX-10.35 a51298exv10w35.htm EX-10.35 34644
4 EX-10.36 a51298exv10w36.htm EX-10.36 37974
5 EX-10.37 a51298exv10w37.htm EX-10.37 34377
6 EX-23.1 a51298exv23w1.htm EX-23.1 1271
7 EX-31.1 a51298exv31w1.htm EX-31.1 8587
8 EX-31.2 a51298exv31w2.htm EX-31.2 8589
9 EX-32.1 a51298exv32w1.htm EX-32.1 6704
10 GRAPHIC a51298a5129801.gif GRAPHIC 6044
11 GRAPHIC a51298a5129802.gif GRAPHIC 12048
  Complete submission text file 0000936392-09-000121.txt   2270639
Mailing Address 3721 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 (858) 480-0400
Somaxon Pharmaceuticals, Inc. (Filer) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51665 | Film No.: 09681023
SIC: 2834 Pharmaceutical Preparations